| Affinity Energy and Health Limited (AEB) ORDINARY FULLY PAID |
Health Care |
- |
Estimated Distribution Announcement
|
27 Feb 2025 5:20PM |
$0.009 |
$0.009 |
fallen by
0%
|
|
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
3 x Change of Directors Interest Notices
|
27 Feb 2025 5:18PM |
$0.800 |
$0.780 |
fallen by
2.50%
|
|
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$63 |
H1 FY2025 - Half Year Results Presentation
|
27 Feb 2025 5:15PM |
$0.125 |
$0.205 |
risen by
64%
|
|
VBC - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY2025 revenue of $42.8 million, down from $50 million in H1 FY2024.
- Gross profit of $15.8 million with a gross margin of 37.0%.
- Third consecutive profitable period since new management began.
- Unweighted opportunity pipeline valued at $131 million.
- Cash reserves stable at $4.5 million.
- Loan debt reduced from $6.6 million to $6.1 million.
- Increased work in hand at $40 million.
- Expansion of operations and maintenance services in Western Australia.
- Competency training locations increased from 6 to 12.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kula Gold Limited (KGD) ORDINARY FULLY PAID |
Materials |
$96 |
Change in substantial holding
|
27 Feb 2025 5:13PM |
$0.005 |
$0.080 |
risen by
1,500%
|
|
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$63 |
H1 FY2025 - Half Year Results Announcement
|
27 Feb 2025 5:13PM |
$0.125 |
$0.205 |
risen by
64%
|
|
VBC - Price-sensitive ASX Announcement
Full Release
Key Points
- Verbrec reports third consecutive profitable period.
- Gross margins reached a record high of 37% in H1 FY2025.
- Revenue declined to $42.8 million compared to $50.0 million in H1 FY2024.
- Cash balances stable at $4.5 million, with debt reduced to $6.1 million.
- Management expects stronger revenues and profits in the second half.
- Work in hand increased to $40 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
Half Year Results Presentation FY25
|
27 Feb 2025 5:09PM |
$0.800 |
$0.780 |
fallen by
2.50%
|
|
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$63 |
H1 FY2025 - Interim Financial Report
|
27 Feb 2025 5:09PM |
$0.125 |
$0.205 |
risen by
64%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$951 |
Update - Dividend/Distribution - IDX
|
27 Feb 2025 5:08PM |
$2.360 |
$2.550 |
risen by
8.05%
|
|
| BetaShares Western Asset Australian Bond Fund (Managed Fund) (BNDS) |
Financials |
$851 |
Estimated Distribution Announcement
|
27 Feb 2025 5:08PM |
$23.670 |
$23.410 |
fallen by
1.10%
|
|
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
Market Update Feb 2025
|
27 Feb 2025 5:07PM |
$0.800 |
$0.780 |
fallen by
2.50%
|
|
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$63 |
H1 FY2025 - Appendix 4D
|
27 Feb 2025 5:04PM |
$0.125 |
$0.205 |
risen by
64%
|
|
VBC - Price-sensitive ASX Announcement
Full Release
Key Points
- Half Year Report for Verbrec Limited for the period ended 31 December 2024.
- Revenue from continuing operations decreased by 14.4% to $42.814 million.
- Profit from continuing operations after tax attributable to members fell by 69.8% to $861,000.
- Net profit for the period increased by 338.1% to $793,000.
- No dividends were proposed for payment during the current or previous period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tartana Minerals Limited (TAT) ORDINARY FULLY PAID |
Materials |
$11 |
Notification regarding unquoted securities - TAT
|
27 Feb 2025 5:03PM |
$0.043 |
$0.045 |
risen by
4.65%
|
|
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
Dividend/Distribution - SHM
|
27 Feb 2025 5:01PM |
$0.800 |
$0.780 |
fallen by
2.50%
|
|
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
Half Yearly Report and Accounts
|
27 Feb 2025 5:00PM |
$0.800 |
$0.780 |
fallen by
2.50%
|
|
SHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased to $55.9 million, down 12.9% from the previous year.
- EBITDA increased by 3.8% to $10.8 million.
- Operating expenses reduced by 20.2% due to business restructuring.
- Net cash stands at $24.7 million.
- Dividend of 2.0 cents per share declared for the half year.
- Company focused on growth through product development and geographic expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kula Gold Limited (KGD) ORDINARY FULLY PAID |
Materials |
$96 |
Notification regarding unquoted securities - KGD
|
27 Feb 2025 4:58PM |
$0.005 |
$0.080 |
risen by
1,500%
|
|
| Kula Gold Limited (KGD) ORDINARY FULLY PAID |
Materials |
$96 |
Notification regarding unquoted securities - KGD
|
27 Feb 2025 4:57PM |
$0.005 |
$0.080 |
risen by
1,500%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$422 |
Appendix 4D and 2024 Half Year Financial Report
|
27 Feb 2025 4:57PM |
$0.025 |
$3.790 |
risen by
15,060%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half-year was $41,048,563.
- The company reported a loss from ordinary activities after tax of $7,280,066.
- Gold sales totaled 10,927 ounces at an average price of $3,914 per ounce.
- Operational highlights include 12,091 ounces of gold produced.
- The Iguana Deposit at Lady Ida has a mineral resource estimate of 609,000 ounces.
- Completed a $10.3 million entitlement issue fully underwritten.
- Exploration activities focused on the Tycho and MacPherson leases.
- Joint venture agreement for Lady Ida Project executed.
- No dividends declared for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kula Gold Limited (KGD) ORDINARY FULLY PAID |
Materials |
$96 |
Application for quotation of securities - KGD
|
27 Feb 2025 4:56PM |
$0.005 |
$0.080 |
risen by
1,500%
|
|
| Asara Resources Limited (AS1) ORDINARY FULLY PAID |
Materials |
$200 |
Becoming a substantial holder
|
27 Feb 2025 4:56PM |
$0.034 |
$0.125 |
risen by
267.65%
|
|
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$327 |
LDA Capital Call Notice
|
27 Feb 2025 4:55PM |
$0.258 |
$0.145 |
fallen by
43.69%
|
|
BRN - Price-sensitive ASX Announcement
Full Release
Key Points
- BrainChip issues Capital Call Notice to LDA Capital to sell up to 40,000,000 shares
- Available funding under the LDA Agreement stands at AUD $74.8M
- Company commences search for a Senior Operations Manager to support its operations
- Company obligated to advance a minimum of 40 million shares to LDA by June 30, 2025
- Issue price of shares will be 91.5% of the higher daily volume weighted average price
- Company intends to use capital to execute on product roadmap and development initiatives
- Significant expansion of the Company’s portfolio of proprietary TENNs based models underway
- Enhancements to the Akida 2.0 platform aimed at a release in the second half of 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cleo Diagnostics Ltd (COV) ORDINARY FULLY PAID |
Health Care |
$83 |
Appendix 4D and Half Yearly Accounts
|
27 Feb 2025 4:53PM |
$0.505 |
$0.605 |
risen by
19.80%
|
|
COV - Price-sensitive ASX Announcement
Full Release
Key Points
- Cleo Diagnostics is developing a blood test for early ovarian cancer diagnosis.
- The test utilizes a patented CXCL10 biomarker.
- Clinical trials have commenced in the U.S. and Australia.
- FDA-enabling trials involve patient recruitment of at least 500 individuals.
- The company plans to submit its application to the FDA by the end of 2025.
- Cleo's financial loss decreased to $1,950,364 for the half-year ended December 2024.
- Cash reserves at the end of the reporting period amounted to $7.311M.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$34 |
Media Release - Half Year Results
|
27 Feb 2025 4:50PM |
$1.700 |
$2.150 |
risen by
26.47%
|
|
CDO - Price-sensitive ASX Announcement
Full Release
Key Points
- Half-year loss after tax of $0.3 million.
- Portfolio down 1.1% over six months.
- Top performance contributors included Echo IQ, Netflix, and Iperionx.
- Major detractors included Whitehaven Coal and BHP.
- Downturn in commodity prices adversely affected investment performance.
- Positive returns from Netflix and Meta Platforms due to turnaround strategies.
- Participation in Echo IQ equity raise provided excellent returns.
- 6.5 cent fully franked interim dividend declared.
- Annualised yield of 7.6% fully franked.
- CDO trading at a 12% discount to NTA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$327 |
BrainChip Evaluates Redomiciling to US
|
27 Feb 2025 4:50PM |
$0.258 |
$0.145 |
fallen by
43.69%
|
|
BRN - Price-sensitive ASX Announcement
Full Release
Key Points
- BrainChip to investigate redomiciling to the US in 2025
- Decision made after extensive strategic review by the Board
- Aim to list on a US-based securities exchange
- Existing shareholders to hold equivalent US-listed securities
- US market provides a larger and more technologically savvy investor base
- Potential for positive re-evaluation and re-pricing of shares
- SEC rules offer greater protection for sensitive information
- Delisting from ASX to reduce regulatory compliance and costs
- Chairman believes decision is in the best interest of all stakeholders
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$34 |
Dividend/Distribution - CDO
|
27 Feb 2025 4:45PM |
$1.700 |
$2.150 |
risen by
26.47%
|
|
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$4,118 |
Change in substantial holding
|
27 Feb 2025 4:44PM |
$14.720 |
$21.310 |
risen by
44.77%
|
|